Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Adaptive in vivo device for theranostics of inflammation: real-time monitoring of interferon-? and aspirin
  2. Cao, Chaomin; Jin, Ronghua; Wei, Hui; Liu, Zhongning; Ni, Shengnan; Liu, Guo-Jun; Young,Howard; Chen, Xin; Liu, Guozhen
  3. Acta biomaterialia. 2020, Jan 1; 101: 372-383.
  1. 2.   Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O-2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as Safe Anti-Inflammatory, Analgesic, Antipyretic, Antioxidant Prodrugs
  2. Chattopadhyay, M.; Velazquez, C. A.; Pruski, A.; Nia, K. V.; Abdellatif, K. R.; Keefer, L. K.; Kashfi, K.
  3. Journal of Pharmacology and Experimental Therapeutics. 2010, Nov; 335(2): 443-450.
  1. 3.   Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cells
  2. Nath, N.; Chattopadhyay, M.; Kodela, R.; Tian, S.; Vlismas, P.; Boring, D.; Crowell, J. A.; Kashfi, K.
  3. Biochemical Pharmacology. 2010, Jun; 79(12): 1759-1771.
  1. 4.   Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells
  2. Moody, T. W.; Switzer, C.; Santana-Flores, W.; Ridnour, L. A.; Berna, M.; Thill, M.; Jensen, R. T.; Sparatore, A.; Del Soldato, P.; Yeh, G. C.; Roberts, D. D.; Giaccone, G.; Wink, D. A.
  3. Lung Cancer. 2010, May; 68(2): 154-160.
  1. 5.   Modulation of Carcinogen Metabolism by Nitric Oxide-Aspirin 2 Is Associated with Suppression of DNA Damage and DNA Adduct Formation
  2. MacDonald, C. J.; Cheng, R.; Roberts, D. D.; Wink, D. A.; Yeh, G. C.
  3. Journal of Biological Chemistry. 2009 284(33): 22099-22107.
  1. 6.   Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer
  2. Daugherty, S. E.; Shugart, Y. Y.; Platz, E. A.; Fallin, M. D.; Isaacs, W. B.; Pfeiffer, R. M.; Welch, R.; Huang, W. Y.; Reding, D.; Hayes, R. B.
  3. Prostate. 2007, Oct; 67(14): 1487-1497.
  1. 7.   Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
  2. Ali, I. U.; Luke, B. T.; Dean, M.; Greenwald, P.
  3. British Journal of Cancer. 2005, OCT 17; 93(8): 953-959.
  1. 8.   Suboptimal prescribing in elderly outpatients: Potentially harmful drug-drug and drug-disease combinations
  2. Zhan, C. L.; Correa-de-Araujo, R.; Bierman, A. S.; Sangl, J.; Miller, M. R.; Wickizer, S. W.; Stryer, D.
  3. Journal of the American Geriatrics Society. 2005, FEB; 53(2): 262-267.
  1. 9.   The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin
  2. MacDonald, C. J.; Ciolino, H. P.; Yeh, G. C.
  3. Cancer Research. 2004 64(1): 429-434.
  1. 10.   Serum proteomic profiles suggest celecoxib-modulated targets and response predictors
  2. Zhen, X. A.; Luke, B. T.; Izmirlian, G.; Umar, A.; Lynch, P. M.; Phillips, R. K. S.; Patterson, S.; Conrads, T. P.; Veenstra, T. D.; Greenwald, P.; Hawk, E. T.; Ali, L. U.
  3. Cancer Research. 2004 64(8): 2904-2909.
  1. 11.   Formyl-peptide receptors revisited
  2. Le, Y. Y.; Murphy, P. M.; Wang, J. M.
  3. Trends in Immunology. 2002 23(11): 541-548.
  1. 12.   Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey
  2. Ratnasinghe, D.; Tangrea, J.; Roth, M. J.; Dawsey, S.; Hu, N.; Anver, M.; Wang, Q. H.; Taylor, P. R.
  3. Anticancer Research. 1999 19(1A): 171-174.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel